Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $101.6100 (0.02%) ($100.9600 - $102.7300) on Fri. Dec. 30, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.09% (three month average) | RSI | 45 | Latest Price | $101.6100(0.02%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.2% a day on average for past five trading days. | Weekly Trend | LGND declines -2.2% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(53%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -1.045% in a week (0% probabilities). TLT(-15%) VIXM(-14%) UUP(-8%) GDXJ(-6%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.045% (StdDev 2.09%) | Hourly BBV | 0 () | Intraday Trend | -0% | | | |
|
1 - 5 Day Possible Target | $98.5(-3.06%) | Resistance Level | $104.62 | 5 Day Moving Average | $102.35(-0.72%) | 10 Day Moving Average | $103.55(-1.87%) | 20 Day Moving Average | $104.62(-2.88%) | To recent high | -7.2% | To recent low | 11.5% | Market Cap | $1.633b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |